NAT9 Polyclonal Antibody
Sizes: 60μL, 120μL, 200μL
Catalogue Numbers: E-AB-67834-60, E-AB-67834-120, E-AB-67834-200
Citations, Manuals and MSDS Available upon request.
Abbreviation: NAT9
Target Synonym: NAT9; EBSP; hNATL
Conjugation: Unconjugated
Host: Rabbit
Species Reactivity: Human
Application: IF
Isotype: IgG
Clonality: Polyclonal
UNIProt ID: Q9BTE0
Background: NAT9 (N-Acetyltransferase 9 (Putative)) is a Protein Coding gene. Diseases associated with NAT9 include Lymphogranuloma Venereum and Granuloma Inguinale. Among its related pathways are Cytochrome P450 - arranged by substrate type. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring acyl groups other than amino-acyl groups and N-acetyltransferase activity.
Concentration: 1mg/mL
Immunogen: Recombinant fusion protein of human NAT9 (NP_056469.2).
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Purification Method: Affinity purification
Dilution: IF 1:50-1:100
Storage: -20°C/One year. Avoid freeze / thaw cycles.
Shipping: Ice bag
Research Use Only